Document is current
Any future updates will be listed below
-
Authors
Ando, Yuichi
Nishiyama, Hiroyuki
Shimodaira, Hideki
Takano, Nao
Sakaida, Emiko
Matsumoto, Koji
Nakanishi, Koki
Sakai, Hideki
Tsukamoto, Shokichi
Komine, Keigo
Yasuda, Yoshinari
Kato, Taigo
Fujiwara, Yutaka
Koyama, Takafumi
Kitamura, Hiroshi
Kuwabara, Takashige
Yonezawa, Atsushi
Okumura, Yuta
Yakushijin, Kimikazu
Nozawa, Kazuki
Goto, Hideaki
Matsubara, Takeshi https://orcid.org/0000-0002-2380-1551
Hoshino, Junichi
Yanagita, Motoko
,
- License Information
-
More Information
Article History
Received: 22 May 2023
Accepted: 28 June 2023
First Online: 16 July 2023
Declarations
:
: Y.A has received honoraria from Chugai Pharmaceutical Co., Ltd., Bayer Holding Ltd., and research funding from Chugai Pharmaceutical Co., Ltd., Geo Holdings Corporation, and BeiGene, Ltd. H.N has received honoraria from MSD K.K., Astellas pharma Inc., and Merck Biopharma Co., Ltd., research fundings from Chugai Pharmaceutical Co. Ltd., and a scholarship donation from Bayer AG. E.S has received honoraria from Pfizer Japan Inc., Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Novartis Pharmaceuticals Corporation, and Janssen Pharmaceutical K.K. K.M has received honoraria from MSD, Kyowa Kirin Co., Ltd., and Chugai-Pharmaceutical Co., Ltd., and research fundings from DAIICHI SANKYO COMPANY, MSD, Eli Lilly Japan K.K, Gilead Sciences, and Eisai Co., Ltd. Y.F has received honoraria from AstraZeneca, Bristol-Myers Squibb Company, Chugai-Pharmaceutical Co., Ltd., DAIICHI SANKYO COMPANY, Micron, MSD, and ONO PHARMACEUTICAL CO., LTD., and research fundings from Abbvie, Amgen, AnHeart, AstraZeneca, Bristol-Myers Squibb Company, Chugai-Pharmaceutical Co., Ltd., Eli Lilly Japan K.K, Incyte, and MSD. T.K has received honoraria from Chugai, AstraZeneca and Sysmex, and research funding from PACT Pharma, Chugai, Daiichi-Sankyo, Novartis, Eli Lilly, Pfizer, Janssen Pharmaceutical K.K., Zymworks, and Takeda Pharmaceutical Company Limited. H.K has received honoraria from Astellas Pharma Inc, Takeda Pharmaceutical Company Limited, Bayer AG, and Janssen Pharmaceutical K.K., and scholarship donations from Takeda Pharmaceutical Company Limited and Bayer AG. T. K received honoraria from AstraZeneca. J.H has received honoraria from Kyowa Kirin Co., Ltd., Mitsubishi Tanabe Pharma, Ono Pharm, AstraZeneca and Astellas Pharma Inc, and a research grant from Otsuka Pharmaceutical Co., Ltd. M. Yanagita has received honoraria from Astellas Pharma Inc, AstraZeneca, Kyowa Kirin Co., Ltd., Chugai-Pharmaceutical Co., Ltd., Bayer AG, and Mitsubishi Tanabe Pharma, and research grants from Mitsubishi Tanabe Pharma, Boehringer Ingelheim International GmbH, and scholarship donations from Kyowa Kirin Co., Ltd., Chugai-Pharmaceutical Co., Ltd., and Mitsubishi Tanabe Pharma. The other authors declare no potential conflicts of interest.
